Atlas Trials

Comparison of the Effect of Rabeprazole 50 mg DDR Capsules and 20 mg Enteric-coated Tablets

Clinical trial NCT03037606 · COMPLETED

Trial details

NCT number
NCT03037606
Sponsor
Neutec Ar-Ge San ve Tic A.Ş
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Gastroesophageal Reflux Disease
Start date
2017-08-01
Primary completion
2018-12-01
Enrollment
48

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.